Results 171 to 180 of about 87,487 (309)

Beta-sitosterols for benign prostatic hyperplasia

, 1999
Timothy J Wilt, Areef Ishani, Roderick MacDonald, Gerold Stark, Cynthia D. Mulrow, Joseph Lau   +5 more
openalex   +2 more sources

Comment on Prostatic Hyperplasia in Patients with Acromegaly [PDF]

, 1998
J Geller
openalex   +1 more source

A Multimarker Model for Prostate Cancer Risk Assessment: Improving Diagnostic Accuracy Beyond PSA

The Prostate, Volume 85, Issue 12, Page 1096-1103, September 2025.
ABSTRACT Objective This study aimed to evaluate the association between biochemical markers and prostate cancer (PCa) risk by analyzing patients with benign prostatic hyperplasia (BPH) and PCa. Additionally, the study sought to assess the diagnostic accuracy of a multimarker model compared to prostate‐specific antigen (PSA) alone.
Penglu Yang, Bin Yang
wiley   +1 more source

Risk factors for benign prostatic hyperplasia: a comprehensive review. [PDF]

Rev Assoc Med Bras (1992)
Siqueira MHB.
europepmc   +1 more source

PRMT5:MEP50 Are Mediators of Treatment‐Induced Neuroendocrine Differentiation in Prostate Cancer

The Prostate, Volume 85, Issue 13, Page 1196-1207, September 15, 2025.
ABSTRACT Background Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer responsible for an estimated 20%–30% of castration‐resistant prostate cancer (CRPC) deaths. While NEPC can arise spontaneously, the majority of these cases emerge as treatment‐induced NEPC (tNEPC).
Hye Seung Nam, Andrew Michael Asberry, Xuehong Deng, Sheng Liu, Jiaoti Huang, Chang‐Deng Hu, Jun Wan, Michael K. Wendt   +7 more
wiley   +1 more source

Examining the effectiveness of Prostatic hyperplasia education on the level of participant's knowledge and awareness. [PDF]

PLoS One
Krismanuel H, Tjhin P.
europepmc   +1 more source

Magnetic resonance imaging‐guided transurethral ultrasound ablation for benign prostatic obstruction: 1‐year clinical outcomes of a phase II study

BJU International, Volume 136, Issue 3, Page 473-483, September 2025.
Objectives To evaluate the safety and efficacy of magnetic resonance imaging (MRI)‐guided transurethral ultrasound ablation (TULSA) as a minimally invasive alternative for benign prostatic obstruction (BPO). Patients and Methods This prospective, single‐centre, early phase II study (NCT03350529) included 30 men with BPO scheduled for primary ...
Antti Viitala, Mikael Anttinen, Pietari Mäkelä, Heikki Pärssinen, Pertti Nurminen, Teija Sainio, Jani Saunavaara, Pekka Taimen, Roberto Blanco Sequeiros, Peter J. Boström   +9 more
wiley   +1 more source

Clinical effectiveness analysis of transurethral vaporization prostatectomy for benign prostatic hyperplasia. [PDF]

Medicine (Baltimore)
Cheng C, Wang L, Yang T, Liao Y, Yan Y, Lu K.   +5 more
europepmc   +1 more source

EFFECTS OF A SAW PALMETTO HERBAL BLEND IN MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA [PDF]

, 2000
Leonard S. Marks, Alan W. Partin, Jonathan I. Epstein, Varro E. Tyler, INPAKALA SIMON, MARIA L. MACAIRAN, THERESA L. CHAN, Frederick J. Dorey, JOEL B. GARRIS, Robert W. Veltri, PAUL BRYAN C. SANTOS, KERRY A. STONEBROOK, Jean B. deKernion   +12 more
openalex   +1 more source

Negative impact of benign prostatic hyperplasia on fertility in dogs-a mini-review. [PDF]

Front Vet Sci
Domosławska-Wyderska A, Zduńczyk S, Rafalska A.   +2 more
europepmc   +1 more source